Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

An Embryo-Fetal Development Study of Tarcocimab after Intravenous Injection in Rabbits

John Sinclair; Janine Lu; Hong Liang; Elise Lewis; Rachel Babineau; Alan Hoberman; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5100.

ARVO Annual Meeting Abstract June 2023

KSI-501 is a novel anti-VEGF and anti-IL-6 bispecific biopolymer conjugate to simultaneously address neovascularization and inflammation in retinal diseases

Jason Lin; Fernando Correa; Namrata Prasad; Lili Liu; Mirna Rodriguez; Michael Ngo; Kim Williams; Janine Lu; Rachel Jacobson; William Ngo; Carrie Lin; Xiaojian Huang; Long Pham; Kiho Song; Hong Liang; Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1153.

ARVO Annual Meeting Abstract June 2023

Biological Benefits of KSI-501: Novel Bispecific Anti-Inflammatory and Anti-Angiogenic Therapy for the Treatment of both Retinal Vascular and Inflammatory Diseases

Kim Williams; Mirna Rodriguez; Wolf-Nicolas Fischer; Rachel Jacobson; Michael Ngo; Namrata Prasad; Lili Liu; Janine Lu; Fernando Correa; Victor Perlroth; Hong Liang

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2215.

ARVO Annual Meeting Abstract June 2021

Biophysical Characterization of Antibody Biopolymer Conjugate (ABC) Platform for Improved Therapy of Retinal Vascular Diseases

Fernando Correa; Carrie Su; Long Pham; Namrata Prasad; Chandrani Chakraborty; Janine Lu; Rachel Jacobson; Bernd Jandeleit; Didier Benoit; Xiaojian Huang; Ashwath Jayagopal; Hong Liang; Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):561.

ARVO Annual Meeting Abstract July 2019

Chronic Nonclinical Ocular Toxicity Study of KSI-301 Demonstrates Tolerability after Intravitreal Administration in Cynomolgus Monkeys

John Sinclair; hong liang; zachary antonio; paul miller; avery tolosa; joel naor; leah quarberg; alok sharma; Xiaojian Huang; Janine Lu; William Ngo; dan dang; frances clemo; James N Ver Hoeve; T. Michael Nork; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):126.

ARVO Annual Meeting Abstract July 2019

Development of Novel Bispecific Anti-Inflammatory and Anti-Angiogenic Therapy for the Treatment of both Retinal Vascular and Inflammatory Diseases

Fernando Correa; Rachel Jacobson; Namrata Prasad; William Ngo; Janine Lu; Carrie Su; Xiaojian Huang; hong liang; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5396.

ARVO Annual Meeting Abstract July 2018

Development of potent dual action biopharmaceuticals for the treatment and prevention of neovascular retinal diseases

Fernando Correa; Rachel DeVay Jacobson; hong liang; Namrata Prasad; Xiaojian Huang; William Ngo; Dan Dang; Janine Lu; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5312.

ARVO Annual Meeting Abstract July 2018

KSI-301: An anti-VEGF antibody biopolymer conjugate with extended half-life for treatment of neovascular retinal diseases

hong liang; Xiaojian Huang; William Ngo; Dan Dang; Janine Lu; Rachel DeVay Jacobson; Ons Harrabi; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):211.

ARVO Annual Meeting Abstract July 2018

Development and characterization of a prototype antibody biopolymer conjugate targeting the complement system

Rachel DeVay Jacobson; Dan Dang; William Ngo; Janine Lu; Amy Duguay; Ons Harrabi; Xiaojian Huang; hong liang; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):219.

Advertisement